Cargando…
‘Real-World’ Impact of Tixagevimab/Cilgavimab (Evusheld) on COVID-19 Outcomes in Patients Undergoing Cellular Therapies
| Autores principales: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899534/ http://dx.doi.org/10.1016/S2666-6367(23)00505-5 |
| _version_ | 1784882656865943552 |
|---|---|
| author | Sannareddy, Aishwarya Reves, Heather Narasimhan, Madhusudhanan Jaleta, Kefyalew Anderson, Julia Marie Patel, Hetalkumari Anderson, Larry D. Afrough, Aimaz Chung, Stephen Collins, Robert H. Kaur, Gurbakhash Kumar, Kiran A Madanat, Yazan F. Vusirikala, Madhuri Awan, Farrukh T Muthukumar, Alagar R Geethakumari, Praveen Ramakrishnan |
| author_facet | Sannareddy, Aishwarya Reves, Heather Narasimhan, Madhusudhanan Jaleta, Kefyalew Anderson, Julia Marie Patel, Hetalkumari Anderson, Larry D. Afrough, Aimaz Chung, Stephen Collins, Robert H. Kaur, Gurbakhash Kumar, Kiran A Madanat, Yazan F. Vusirikala, Madhuri Awan, Farrukh T Muthukumar, Alagar R Geethakumari, Praveen Ramakrishnan |
| author_sort | Sannareddy, Aishwarya |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9899534 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98995342023-02-06 ‘Real-World’ Impact of Tixagevimab/Cilgavimab (Evusheld) on COVID-19 Outcomes in Patients Undergoing Cellular Therapies Sannareddy, Aishwarya Reves, Heather Narasimhan, Madhusudhanan Jaleta, Kefyalew Anderson, Julia Marie Patel, Hetalkumari Anderson, Larry D. Afrough, Aimaz Chung, Stephen Collins, Robert H. Kaur, Gurbakhash Kumar, Kiran A Madanat, Yazan F. Vusirikala, Madhuri Awan, Farrukh T Muthukumar, Alagar R Geethakumari, Praveen Ramakrishnan Transplant Cell Ther Poster Session: Infectious Diseases and Cytotoxic T Lymphocytes American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. 2023-02 2023-02-06 /pmc/articles/PMC9899534/ http://dx.doi.org/10.1016/S2666-6367(23)00505-5 Text en Copyright © 2023 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Poster Session: Infectious Diseases and Cytotoxic T Lymphocytes Sannareddy, Aishwarya Reves, Heather Narasimhan, Madhusudhanan Jaleta, Kefyalew Anderson, Julia Marie Patel, Hetalkumari Anderson, Larry D. Afrough, Aimaz Chung, Stephen Collins, Robert H. Kaur, Gurbakhash Kumar, Kiran A Madanat, Yazan F. Vusirikala, Madhuri Awan, Farrukh T Muthukumar, Alagar R Geethakumari, Praveen Ramakrishnan ‘Real-World’ Impact of Tixagevimab/Cilgavimab (Evusheld) on COVID-19 Outcomes in Patients Undergoing Cellular Therapies |
| title | ‘Real-World’ Impact of Tixagevimab/Cilgavimab (Evusheld) on COVID-19 Outcomes in Patients Undergoing Cellular Therapies |
| title_full | ‘Real-World’ Impact of Tixagevimab/Cilgavimab (Evusheld) on COVID-19 Outcomes in Patients Undergoing Cellular Therapies |
| title_fullStr | ‘Real-World’ Impact of Tixagevimab/Cilgavimab (Evusheld) on COVID-19 Outcomes in Patients Undergoing Cellular Therapies |
| title_full_unstemmed | ‘Real-World’ Impact of Tixagevimab/Cilgavimab (Evusheld) on COVID-19 Outcomes in Patients Undergoing Cellular Therapies |
| title_short | ‘Real-World’ Impact of Tixagevimab/Cilgavimab (Evusheld) on COVID-19 Outcomes in Patients Undergoing Cellular Therapies |
| title_sort | ‘real-world’ impact of tixagevimab/cilgavimab (evusheld) on covid-19 outcomes in patients undergoing cellular therapies |
| topic | Poster Session: Infectious Diseases and Cytotoxic T Lymphocytes |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899534/ http://dx.doi.org/10.1016/S2666-6367(23)00505-5 |
| work_keys_str_mv | AT sannareddyaishwarya realworldimpactoftixagevimabcilgavimabevusheldoncovid19outcomesinpatientsundergoingcellulartherapies AT revesheather realworldimpactoftixagevimabcilgavimabevusheldoncovid19outcomesinpatientsundergoingcellulartherapies AT narasimhanmadhusudhanan realworldimpactoftixagevimabcilgavimabevusheldoncovid19outcomesinpatientsundergoingcellulartherapies AT jaletakefyalew realworldimpactoftixagevimabcilgavimabevusheldoncovid19outcomesinpatientsundergoingcellulartherapies AT andersonjuliamarie realworldimpactoftixagevimabcilgavimabevusheldoncovid19outcomesinpatientsundergoingcellulartherapies AT patelhetalkumari realworldimpactoftixagevimabcilgavimabevusheldoncovid19outcomesinpatientsundergoingcellulartherapies AT andersonlarryd realworldimpactoftixagevimabcilgavimabevusheldoncovid19outcomesinpatientsundergoingcellulartherapies AT afroughaimaz realworldimpactoftixagevimabcilgavimabevusheldoncovid19outcomesinpatientsundergoingcellulartherapies AT chungstephen realworldimpactoftixagevimabcilgavimabevusheldoncovid19outcomesinpatientsundergoingcellulartherapies AT collinsroberth realworldimpactoftixagevimabcilgavimabevusheldoncovid19outcomesinpatientsundergoingcellulartherapies AT kaurgurbakhash realworldimpactoftixagevimabcilgavimabevusheldoncovid19outcomesinpatientsundergoingcellulartherapies AT kumarkirana realworldimpactoftixagevimabcilgavimabevusheldoncovid19outcomesinpatientsundergoingcellulartherapies AT madanatyazanf realworldimpactoftixagevimabcilgavimabevusheldoncovid19outcomesinpatientsundergoingcellulartherapies AT vusirikalamadhuri realworldimpactoftixagevimabcilgavimabevusheldoncovid19outcomesinpatientsundergoingcellulartherapies AT awanfarrukht realworldimpactoftixagevimabcilgavimabevusheldoncovid19outcomesinpatientsundergoingcellulartherapies AT muthukumaralagarr realworldimpactoftixagevimabcilgavimabevusheldoncovid19outcomesinpatientsundergoingcellulartherapies AT geethakumaripraveenramakrishnan realworldimpactoftixagevimabcilgavimabevusheldoncovid19outcomesinpatientsundergoingcellulartherapies |